Company Armoriapharm Srl with Fiscal Code 14534238
recorded a turnover of 2024 of
48.951,
with a net profit of
9.494
and having an average number of employees of
2.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Armoriapharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
0
4.520
13.835
27.227
32.874
14.471
21.226
35.121
38.168
48.951
Total Income - EUR
0
4.520
13.835
27.227
32.874
14.471
21.226
35.121
38.799
51.683
Total Expenses - EUR
0
4.232
12.655
18.540
25.680
6.078
14.353
27.721
35.605
41.672
Gross Profit/Loss - EUR
0
288
1.180
8.687
7.194
8.393
6.873
7.401
3.194
10.011
Net Profit/Loss - EUR
0
288
1.042
8.415
6.866
8.249
6.661
7.049
2.806
9.494
Employees
0
0
0
2
0
0
0
0
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 29.0%, from 38.168 euro in the year 2023, to 48.951 euro in 2024.
The Net Profit increased by 6.703 euro, from 2.806 euro in 2023, to 9.494 in the last year.
Check the financial reports for the company - Armoriapharm Srl
Financial Rating - ARMORIAPHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Armoriapharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Armoriapharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Armoriapharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
66.747 euro in 2024 which includes Inventories of
58.569 euro, Receivables of
7.646 euro and cash availability of
531 euro.
The company's Equity was valued at
39.208 euro, while total Liabilities amounted to
27.539 euro.
Equity increased by 9.494 euro, from 29.881 euro in 2023, to 39.208 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Armoriapharm Srl